Janssen Vaccines & Prevention B.v.

Beth Israel Deaconess Medical Center, Inc.

Danielle Van Manen

Dan H Barouch

Maria Grazia Pau

Johannes Petrus Maria Langedijk

Jort Vellinga

Benoit Christophe Stephan Callendret

Frank Wegmann

Anders Krarup

Johanna Schuitemaker

Frank Tomaka

Jörn Stitz

Jennifer Anne Hendriks

Johannes Petrus Langedijk

Benoit C S Callendret

Benoit Christophe Callendret

Jorn Stitz

Compositions and vaccine combinations containing synthetic HIV envelope proteins, and methods for inducing an immune response against human immunodeficiency virus (HIV) infection are described. Viral expression vectors encoding the synthetic HIV envelope proteins can be used in the vaccine combinations to induce immune responses against HIV and provide improved protective immunity against HIV.

Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins

Compositions, vaccines and methods for inducing an immunity, including a protective immunity, against Human Immunodeficiency Virus (HIV) infection are described. Heterologous vaccine combinations of one or more adenovirus 26 vectors using for priming immunization and an isolated HIV antigenic polypeptide in combination with one or more MVA vectors for boosting immunization induced strong protective immunity against infections by one or multiple clades of HIV.

Compositions and methods for inducing protective immunity against human immunodeficiency virus infection

Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens

Compositions, vaccines and methods for inducing protective immunity against Human Immunodeficiency Virus (HIV) infection are described. Heterologous vaccine combinations of one or more viral expression vectors and an isolated antigenic polypeptide induced strong protective immunity against infections by one or multiple clades of HIV.

Methods for inducing protective immunity against human immunodeficiency virus infection

Synthetic HIV envelope proteins, vectors and compositions thereof, and methods for inducing protective immunity against human immunodeficiency virus (HIV) infection are described. Viral expression vectors encoding the synthetic HIV envelope proteins can be used in vaccines to provide improved protective immunity against HIV.

Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof

Methods and compositions for inducing protective immunity against human immunodeficiency virus infection

Growing community of inventors

Leiden, Netherlands

Danielle Van Manen